The award is presented to an organization for ‘creating a new idea, practice, or product that has had a positive impact on food safety, thus improving public health, and the quality of life’.
It was won by the firm at the IAFP Annual Meeting in Tampa, for its system to validate the efficacy of food processing technologies.
Novolyze has developed dried surrogate bacteria (SurroNov) which are harmless microorganisms that mimic resistance of foodborne pathogens.
Due to their non-pathogenicity, they are used in facilities to evaluate the efficacy of processes to kill pathogens.
Novolyze said it offers industry a way to perform process validation studies needed for food safety regulations such as the Food Safety Modernization Act (FSMA) Final Rule for Preventive Controls.
Karim-Franck Khinouche, founder of Novolyze, said: “It is for us the recognition of more than five years of R&D since Novolyze was founded in 2012.
“Novolyze now has offices both in France, where our head office is located, as well as in the US (Cambridge, Massachusetts). This award encourages us to pursue our continuous efforts to bring innovative solutions to today and tomorrow’s challenges of the food industry.”